Choi et al. developed CMG002, a novel PI3K/mTOR dual inhibitor, and demonstrated that CMG002 is the first-ever compound that inhibits the growth of chemoresistant cancer cells in both vivo and vitro. Here, PIK3CA is linked to cancer.